Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bradpalm1 who wrote (3025)	3/25/1998 6:34:00 PM
From: Claud B	Read Replies (3) \| Respond to of 7041

Bradpalm1 This time I don't have to talk out of turn. Your timing is so far off it's pathetic. The FDA requires a certain number of patients who have been in the trials for 1 year before an NDA can be filed. This number has already been far exceeded by Zonagen so that their timetable with regard to an NDA filing is on track with their announced target date. Claud

To: Bradpalm1 who wrote (3025)	3/25/1998 8:19:00 PM
From: Dauntless	Respond to of 7041

I guess that depends it might not be so bad - - milestone revenue from SGP ($37 million left) - revenue from sales in Mexico & South America before the end of the year (I happened to read just yesterday that Brazil's population is 160 million) - progress on other development projects doesn't sound so bad to me. Besides, it's always hot in Houston in the summer - is that what you meant. I understand that you're a PFE fan, what I don't understand is why you're so intent about the total collapse of Zonagen. It seems that nothing else will please you. What is your problem - did you lose $$$ on Zonagen? Maybe you should join one of the many lawsuits